Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol for secondary hyperparathyroidism in hemodialysis patients
NL-OMON24070Phase 4Recruiting
- Sponsor
- OLVG West
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by OLVG West. Started Jul 2008; status: recruiting.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NL-OMON24070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24070.